Cargando…
Author Correction: HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
Autores principales: | Liang, Chao, Li, Jie, Lu, Cheng, Xie, Duoli, Liu, Jin, Zhong, Chuanxin, Wu, Xiaohao, Dai, Rongchen, Zhang, Huarui, Guan, Daogang, Guo, Baosheng, He, Bing, Li, Fangfei, He, Xiaojuan, Zhang, Wandong, Zhang, Bao-Ting, Zhang, Ge, Lu, Aiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308310/ https://www.ncbi.nlm.nih.gov/pubmed/32572032 http://dx.doi.org/10.1038/s41467-020-16901-6 |
Ejemplares similares
-
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
por: Liang, Chao, et al.
Publicado: (2019) -
Effect of CRP and Kinetics of CRP in Prognosis of Nasopharyngeal Carcinoma
por: Chen, Ruiwan, et al.
Publicado: (2019) -
Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial
por: Zhang, Chi, et al.
Publicado: (2019) -
The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA
por: Cheng, Rui, et al.
Publicado: (2023) -
CRP - Part 2
por: BASEC,
Publicado: (2023)